Vascular purpura and cryoglobulinémia: the difficulties of pharmacovigilance
Sentenac, L.; Chassany, O.; Mathieu, E.; Guillot-Raimbaud, B.; Efthymiou, M.L.; Caulin, C.
Presse Medicale 25(27): 1259
1996
ISSN/ISBN: 0755-4982 PMID: 8949743 Document Number: 469010
Document emailed within 1 workday
Related Documents
Lefrere, J.J.; Courouce, A.M.; Bigorie, B.; Truchaud, F.; Muller, J.Y.; Soulier, J.P. 1985: Vascular purpura caused by human parvoviruses Presse Medicale 14(40): 2065Lefrere, J.J.; Courouce, A.M.; Briand, M.; Soulier, J.P. 1986: Vascular purpura associated with an infection caused by human parvovirus Annales de Pediatrie 33(5): 409-411
Fey, M.F.; Beck, E.A. 1986: Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient Journal of Clinical Psychiatry 47(7): 386-387
Ambriz-Fernández, R.; Sinco-Angeles, A.; Avilés-Miranda, A.; Chávez-Vela, J.; Pizzuto-Chávez, J. 1983: Idiopathic thrombocytopenic purpura in 225 adult cases. use of delayed action prednisone in chronic purpura Gaceta Medica de Mexico 119(4): 164-168
Klein, P.J.; Löhrs, U.; Hübner, G.; Lennartz, K.J. 1971: Moschcowitz-syndrome. Common synonyms: thrombotic-thrombocytic purpura; thrombohemolytic thrombocytopenic purpura, thrombotic microangiopathy Die Medizinische Welt 23: 949-953
Saussele, T. 2014: Pharmacovigilance in the pharmacy Medizinische Monatsschrift für Pharmazeuten 37(10): 353
Montastruc, J.L.; Bagheri, H.; Geraud, T.; Lapeyre-Mestre, M. 1997: Pharmacovigilance of self-medication Therapie 52(2): 105-110
Wang, H-yu. 2010: Vascular medicine:vascular health evaluation and vascular disease prevention and medication Zhonghua Yi Xue Za Zhi 90(30): 2092-2093
Fletcher, A.P. 2000: EU pharmacovigilance guidelines. Review Adverse Drug Reactions and Toxicological Reviews 19(2): 123-126
Gershon, S.; Yeragani, V.K.; Aleem, A. 1986: Tolerance and pharmacovigilance of trazodone L'Encephale 12(Special Issue): 249-257
Livio, F.ço.; Ivanyuk, A.; Biollaz, J.ér.ôm. 2009: Pharmacovigilance and teratovigilance 2008 Revue Medicale Suisse 5(186): 130-134
Doogue, M. 2006: Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance New Zealand Medical Journal 119(1246): U2334
Karpatkin, S.; Nardi, M.A. 1988: Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia Journal of Laboratory and Clinical Medicine 111(4): 441-448
Chiewvit, P.; Tritrakam, S-On.; Kraumak, T. 2015: Computed tomography evaluation of intracranial vascular calcification in major ischemic stroke patients (vascular territory)--its distribution and association with vascular risk factors: a retrospective trial Journal of the Medical Association of Thailand 98(4): 414-422
Monteagudo, J.L. 1996: Data exchange in the European pharmacovigilance Studies in Health Technology and Informatics 28: 69-77
Dhanani, A.; Castot, A. 2000: The European pharmacovigilance: regulatory aspects Presse Medicale 29(2): 107-110
Adams, S.A. 2013: Using patient-reported experiences for pharmacovigilance? Studies in Health Technology and Informatics 194: 63-68
2006: Free access to pharmacovigilance data Prescrire International 15(84): 138
Dupuch, M.; Lerch, M.; Jamet, A.; Jaulent, M.-C.; Fescharek, R.; Grabar, N. 2011: Grouping pharmacovigilance terms with semantic distance Studies in Health Technology and Informatics 169: 794-798
Lampton, L. 2004: Vioxx, pharmacovigilance, flu vaccine, and the "prepared mind" Journal of the Mississippi State Medical Association 45(11): 333-335